265. 脂肪萎縮症 Lipodystrophy Clinical trials / Disease details

臨床試験数 : 112 / 薬物数 : 155 - (DrugBank : 55) / 標的遺伝子数 : 25 - 標的パスウェイ数 : 97

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00227500 (ClinicalTrials.gov)	July 2001	27/9/2005	Pravastatin for Hyperlipidaemia in HIV.	A Randomised, Double-Blind Study of Pravastatin for the Treatment of Hyperlipidaemia in Patients With HIV	HIV Infections;Lipid Metabolism;Glucose Metabolism;Metabolic Abnormality;Lipodystrophy;Cardiovascular Disease	Drug: Pravastatin	Kirby Institute	The University of New South Wales;National Heart, Lung, and Blood Institute (NHLBI);Garvan Institute of Medical Research;St Vincent's Hospital, Sydney	Completed	18 Years	N/A	Both	40	Phase 4	Australia
2	NCT00017758 (ClinicalTrials.gov)	June 2001	11/6/2001	The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering Drugs	The Effect of Efavirenz and Nelfinavir on the Pharmacokinetics of Hydroxymethylglutaryl Coenzyme A Reductase Inhibitors	HIV Infections;HIV Seronegativity;Lipodystrophy	Drug: Pravastatin sodium;Drug: Simvastatin;Drug: Atorvastatin calcium;Drug: Nelfinavir mesylate;Drug: Efavirenz	National Institute of Allergy and Infectious Diseases (NIAID)	NULL	Completed	18 Years	60 Years	Both	56	Phase 1	United States
3	NCT00006412 (ClinicalTrials.gov)	October 25, 2000	13/10/2000	Safety and Effectiveness of Fenofibrate and Pravastatin in HIV-Positive Patients With Abnormal Blood Lipids	A Prospective, Multicenter, Randomized Trial Comparing the Efficacy and Safety of Fenofibrate Versus Pravastatin in HIV-Infected Subjects With Lipid Abnormalities	HIV Infections;Lipodystrophy	Drug: Pravastatin sodium;Drug: Fenofibrate	National Institute of Allergy and Infectious Diseases (NIAID)	NULL	Completed	18 Years	N/A	All	630	Phase 3	United States;Puerto Rico